A study conducted at the Lady Davis Institute at the Jewish General Hospital revealed that pioglitazone is associated with a risk of bladder cancer that increases with duration of use and dosage.
Landmark Clinical Trial of a Novel Combination Treatment for Type 1 Diabetes Begins at Jewish General Hospital and Ï㽶ÊÓƵ Health Centre